We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IDEX Q3 Earnings Surpass Estimates, Sales Increase Year Over Year
Read MoreHide Full Article
Key Takeaways
IDEX posted Q3 adjusted EPS of $2.03, up 7% year over year and above the consensus estimate.
Revenues rose 10% to $879 million, led by 22% growth in Health & Science Technologies.
Adjusted EBITDA climbed 11.9% to $239.8 million, with margin improving to 27.3%.
IDEX Corporation’s (IEX - Free Report) third-quarter 2025 adjusted earnings of $2.03 per share surpassed the Zacks Consensus Estimate of $1.93. The bottom line increased 7% on a year-over-year basis. Management projected adjusted earnings to be in the band of $1.90-$1.95 per share in the quarter.
IEX’s Revenue Details
IDEX’s net sales of $879 million beat the Zacks Consensus Estimate of $858.3 million. The top line increased 10% year over year. Organic sales increased 5% year over year. While acquisitions/divestitures had a positive impact on sales of 4%, foreign currency translation had a positive impact of 1% on sales.
IEX reports net sales under three business segments, the results of which are discussed below:
Net sales from the Fluid & Metering Technologies segment totaled $317.1 million, up 5% year over year. Our estimate for segmental net sales was $297.3 million. Organic sales increased 4% year over year. Foreign currency translation had a positive impact of 1% on sales.
Net sales from the Health & Science Technologies segment totaled $381.0 million, up 22% year over year. Our estimate for segmental net sales was $363.9 million. Organic sales increased 10% year over year. Acquisitions/divestitures and foreign currency translation had a positive impact of 11% and 1%, respectively, on sales.
Net sales from the Fire & Safety/Diversified Products segment totaled $181.9 million, which decreased 3% year over year. Our estimate for segmental net sales was $195.1 million. Organic sales decreased 5% on a year-over-year basis, while foreign currency translation had a favorable impact of 2% on sales.
IDEX Corporation Price, Consensus and EPS Surprise
IDEX’s cost of sales increased 9.9% year over year to $488.1 million. The adjusted gross profit was $391.2 million, up 9.9% year over year. The adjusted gross margin was 44.5% compared with 44.6% in the year-ago quarter.
Selling, general and administrative expenses increased 11.9% year over year to $204.7 million. Adjusted EBITDA was $239.8 million, up 11.9% from the year-ago quarter figure. The adjusted EBITDA margin increased 40 bps year over year to 27.3%.
The operating income was $185.8 million, up 10.6% year over year. The operating margin was 21.1%, up 10 bps year over year. Interest expenses (net) increased 60.2% year over year to $16.5 million.
Balance Sheet and Cash Flow of IDEX
While exiting the third quarter, IDEX’s cash and cash equivalents were $593.8 million compared with $620.8 million at the end of fourth-quarter 2024. Long-term borrowings (net) were $1.90 billion compared with $1.86 billion at the end of fourth-quarter 2024.
In the first nine months of 2025, IDEX generated net cash of $470.9 million from operating activities, down 5% from the year-ago period. Capital expenditures were $43.9 million compared with $49.6 million in the first nine months of 2024. In the same period, free cash flow was $427.0 million, down 4.2% year over year.
IDEX paid out dividends totaling $159.4 million in the first nine months of 2025, up 4.2% year over year.
IDEX’s Outlook
For 2025, the company anticipates adjusted earnings to be in the range of $7.86 - $7.91 per share compared with $7.85 - $7.95 expected earlier. IEX reported adjusted earnings of $7.89 per share in 2024. On a GAAP basis, earnings are predicted to be in the band of $6.35-$6.40 per share.
Organic sales are predicted to increase approximately 1%.
IEX’s Zacks Rank
The company currently carries a Zacks Rank #4 (Sell).
Dover Corporation (DOV - Free Report) reported earnings of $2.62 per share in third-quarter 2025, beating the Zacks Consensus Estimate of $2.50. This compares with earnings of $2.27 per share a year ago.
Dover posted revenues of $2.08 billion in the quarter, missing the Zacks Consensus Estimate by 0.6%. This compares with year-ago revenues of $1.98 billion.
Ardagh Metal Packaging S.A. (AMBP - Free Report) came out with earnings of eight cents per share in the third quarter of 2025, beating the Zacks Consensus Estimate of seven cents. This compares with earnings of eight cents per share a year ago.
Ardagh Metal posted revenues of $1.43 billion in the quarter, beating the Zacks Consensus Estimate by 2.7%. This compares with year-ago revenues of $1.31 billion.
Packaging Corporation of America (PKG - Free Report) reported earnings of $2.73 per share in the third quarter, missing the Zacks Consensus Estimate of $2.83. This compares with earnings of $2.65 per share a year ago.
Packaging Corp. posted revenues of $2.31 billion in the quarter, surpassing the Zacks Consensus Estimate by 2.2%. This compares with year-ago revenues of $2.18 billion.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
IDEX Q3 Earnings Surpass Estimates, Sales Increase Year Over Year
Key Takeaways
IDEX Corporation’s (IEX - Free Report) third-quarter 2025 adjusted earnings of $2.03 per share surpassed the Zacks Consensus Estimate of $1.93. The bottom line increased 7% on a year-over-year basis. Management projected adjusted earnings to be in the band of $1.90-$1.95 per share in the quarter.
IEX’s Revenue Details
IDEX’s net sales of $879 million beat the Zacks Consensus Estimate of $858.3 million. The top line increased 10% year over year. Organic sales increased 5% year over year. While acquisitions/divestitures had a positive impact on sales of 4%, foreign currency translation had a positive impact of 1% on sales.
IEX reports net sales under three business segments, the results of which are discussed below:
Net sales from the Fluid & Metering Technologies segment totaled $317.1 million, up 5% year over year. Our estimate for segmental net sales was $297.3 million. Organic sales increased 4% year over year. Foreign currency translation had a positive impact of 1% on sales.
Net sales from the Health & Science Technologies segment totaled $381.0 million, up 22% year over year. Our estimate for segmental net sales was $363.9 million. Organic sales increased 10% year over year. Acquisitions/divestitures and foreign currency translation had a positive impact of 11% and 1%, respectively, on sales.
Net sales from the Fire & Safety/Diversified Products segment totaled $181.9 million, which decreased 3% year over year. Our estimate for segmental net sales was $195.1 million. Organic sales decreased 5% on a year-over-year basis, while foreign currency translation had a favorable impact of 2% on sales.
IDEX Corporation Price, Consensus and EPS Surprise
IDEX Corporation price-consensus-eps-surprise-chart | IDEX Corporation Quote
IDEX’s Margin Profile
IDEX’s cost of sales increased 9.9% year over year to $488.1 million. The adjusted gross profit was $391.2 million, up 9.9% year over year. The adjusted gross margin was 44.5% compared with 44.6% in the year-ago quarter.
Selling, general and administrative expenses increased 11.9% year over year to $204.7 million. Adjusted EBITDA was $239.8 million, up 11.9% from the year-ago quarter figure. The adjusted EBITDA margin increased 40 bps year over year to 27.3%.
The operating income was $185.8 million, up 10.6% year over year. The operating margin was 21.1%, up 10 bps year over year. Interest expenses (net) increased 60.2% year over year to $16.5 million.
Balance Sheet and Cash Flow of IDEX
While exiting the third quarter, IDEX’s cash and cash equivalents were $593.8 million compared with $620.8 million at the end of fourth-quarter 2024. Long-term borrowings (net) were $1.90 billion compared with $1.86 billion at the end of fourth-quarter 2024.
In the first nine months of 2025, IDEX generated net cash of $470.9 million from operating activities, down 5% from the year-ago period. Capital expenditures were $43.9 million compared with $49.6 million in the first nine months of 2024. In the same period, free cash flow was $427.0 million, down 4.2% year over year.
IDEX paid out dividends totaling $159.4 million in the first nine months of 2025, up 4.2% year over year.
IDEX’s Outlook
For 2025, the company anticipates adjusted earnings to be in the range of $7.86 - $7.91 per share compared with $7.85 - $7.95 expected earlier. IEX reported adjusted earnings of $7.89 per share in 2024. On a GAAP basis, earnings are predicted to be in the band of $6.35-$6.40 per share.
Organic sales are predicted to increase approximately 1%.
IEX’s Zacks Rank
The company currently carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance of Other Companies
Dover Corporation (DOV - Free Report) reported earnings of $2.62 per share in third-quarter 2025, beating the Zacks Consensus Estimate of $2.50. This compares with earnings of $2.27 per share a year ago.
Dover posted revenues of $2.08 billion in the quarter, missing the Zacks Consensus Estimate by 0.6%. This compares with year-ago revenues of $1.98 billion.
Ardagh Metal Packaging S.A. (AMBP - Free Report) came out with earnings of eight cents per share in the third quarter of 2025, beating the Zacks Consensus Estimate of seven cents. This compares with earnings of eight cents per share a year ago.
Ardagh Metal posted revenues of $1.43 billion in the quarter, beating the Zacks Consensus Estimate by 2.7%. This compares with year-ago revenues of $1.31 billion.
Packaging Corporation of America (PKG - Free Report) reported earnings of $2.73 per share in the third quarter, missing the Zacks Consensus Estimate of $2.83. This compares with earnings of $2.65 per share a year ago.
Packaging Corp. posted revenues of $2.31 billion in the quarter, surpassing the Zacks Consensus Estimate by 2.2%. This compares with year-ago revenues of $2.18 billion.